Danaher Corporation (NYSE: DHR), a Washington, DC-based life sciences and diagnostics company, acquired Genedata AG, a Basel, Switzerland-based provider of software solutions for biopharmaceutical R&D.
The amount of the deal was not disclosed.
With the acquisition, Danaher will expand its offerings.
Genedata delivers scalable and open solutions that enhance R&D productivity, serving biopharmaceutical companies and innovative biotechnology organizations.
Danaher is a life sciences and diagnostics company whose solutions enable businesses to partner closely with customers to help solve important health challenges impacting patients around the world. Its advanced science and technology enable accurate diagnoses and help reduce the time and cost needed to sustainably discover, develop and deliver life-changing therapies.
FinSMEs
20/08/2024